Latest hypoglycemia Stories
Researchers from Mount Sinai School of Medicine have discovered a novel function of brain insulin, indicating that impaired brain insulin action may be the cause of the unrestrained lipolysis that initiates and worsens type 2 diabetes in humans.
New approach lowers blood sugar in both type 1 and type 2 diabetes BOSTON, Feb. 13, 2011 /PRNewswire-USNewswire/ -- Diabetes can result from either a deficiency of insulin (type 1 or insulin-dependent diabetes) or decreased sensitivity to insulin (type 2 diabetes).
COPENHAGEN, Denmark, February 2, 2011 /PRNewswire-FirstCall/ -- - Lixisenatide Meets Primary Efficacy Endpoint With Fewer Hypoglycaemias Zealand Pharma A/S (NASDAQ OMX: ZEAL), a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary...
About 1 million people are affected by type 1 diabetes in the United States.
Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone.
ALEXANDRIA, Va., Jan. 26, 2011 /PRNewswire/ -- Ginger Vieira's new book, "Your Diabetes Science Experiment," is designed to help individuals better understand and manage mysterious high blood sugars and unexpected low blood sugars.
PRINCETON, N.J., Jan. 13, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, has launched a comprehensive, highly customizable online support program for people living with diabetes called Cornerstones4Care(TM).
ALAMEDA, Calif., Dec.
Strips sold in retail stores, online and used in health care facilities SILVER SPRING, Md., Dec. 22, 2010 /PRNewswire-USNewswire/ --The U.S.
INDIANAPOLIS and PRINCETON, N.J., Dec. 16, 2010 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, has partnered with Chip Ganassi Racing, LLC to create the Novo Nordisk Chip Ganassi Racing team for 2011 IZOD IndyCar season.
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
- totally perplexed and mixed up.